Case report: Radiotherapy plus pneumococcal conjugate vaccine stimulates abscopal immune response in a patient with ALK+ NSCLC

Most patients with anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer (NSCLC) could benefit from the treatment with selected tyrosine kinase inhibitors (TKIs) for a period of time, but almost inevitably progress due to drug resistance. It was reported that these patients were gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yong-Sheng, Li, Zhuo, Xiao, Ze-Fen, Li, Dan, Liu, Wen-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403065/
https://www.ncbi.nlm.nih.gov/pubmed/36032102
http://dx.doi.org/10.3389/fimmu.2022.950252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403065/
https://www.ncbi.nlm.nih.gov/pubmed/36032102
http://dx.doi.org/10.3389/fimmu.2022.950252

Ejemplares similares